semaglutide ulcerative colitis Adjunctive GLP1 Receptor Agonists in Patients With Inflammatory Bowel Diseases and Obesity and/or Diabetes: A Target Trial Emulation What Experts Say About GLP-1s

Who Different Oral Peptide Formats May Appeal To Oral peptide optionswhether FDA-approved or compoundedmay align well with certain consumer profiles: People Who Prefer Needle-Free Administration: If you experience needle aversion or simply prefer not to self-inject, oral formats including sublingual drops and daily tablets offer practical alternatives to injectable options

Focus your energy where it actually changes the bill: prior authorizations and diagnosis coding, comparing pharmacy prices by NDC, and asking your provider about clinically appropriate, lower-cost alternatives

There is also a trial specifically testing whether retatrutide prevents heart attacks and strokes (TRIUMPH-3, 1,800 people), and a head-to-head trial comparing retatrutide directly against tirzepatide (the active ingredient in Zepbound) under identical conditions (NCT06662383, 800 patients)

People with sensitive skin should avoid skin irritation by patch-testing first or avoiding these products entirely

Invite your colleagues